0.1896
0.0000
(0.00%)
At close: January 10 at 3:00:00 PM EST
Breakdown
TTM
8/31/2024
8/31/2023
8/31/2022
8/31/2021
Operating Cash Flow
-321.3600
-321.3600
-339.6560
-625.3710
-173.5730
Investing Cash Flow
-226.4190
-226.4190
-506.7350
-994.8710
629.2150
Financing Cash Flow
772.1160
772.1160
189.2950
--
2,016.7380
End Cash Position
419.3790
419.3790
195.0420
852.1380
2,472.3800
Capital Expenditure
-226.4190
-226.4190
-506.7350
-994.8710
-262.1850
Issuance of Capital Stock
697.1160
697.1160
--
--
83.4440
Free Cash Flow
-547.7790
-547.7790
-846.3910
-1,620.2420
-435.7580
8/31/2021 - 5/18/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BETRF BetterLife Pharma Inc.
0.0800
0.00%
HAVLF HAVN Life Sciences Inc.
0.0010
0.00%
CLABF Core One Labs Inc.
0.0301
-24.75%
ARGNF argenx SE
655.00
0.00%
PHRRF PharmaTher Holdings Ltd.
0.1600
+6.67%
BIXT Bioxytran, Inc.
0.0984
+15.58%
MBX.TO Microbix Biosystems Inc.
0.4200
+1.20%
COV.V Covalon Technologies Ltd.
3.2000
+3.23%
CYBN.NE Cybin Inc.
12.85
-7.22%
ATAI Atai Life Sciences N.V.
1.5000
-7.41%